Oriental Resources Development Limited (ORDL) is driven by the mission to “improve global quality of life through innovation” and dedicated to the medical device and healthcare industry. ORDL has been honored with the 28th “Rising Star Award” by the Small and Medium-Sized Enterprise Administration, Ministry of Economic Affairs. This prestigious award recognizes Taiwanese small and medium-sized enterprises that have shown exceptional performance in international markets and exports, highlighting their crucial roles in the global supply chain.
ORDL is the only company within the Far Eastern Group dedicated to medical device manufacturing. Since becoming independent from the group’s Biomedical Business Unit in 2008, the company has continued to receive strong support from the group. The company focuses on the research, development, and production of medical products such as bone grafts and wound dressings. Among its product lines, acne dressings supplied to international brands have earned high recognitions for their outstanding quality and strong market competitiveness. ORDL’s export markets have expanded to Canada, the United States, Thailand, Indonesia, Singapore, Philippines, Malaysia and Brazil.
Besides, ORDL manufactures wound dressings and calcium alginate dressings for publicly listed medical device companies in Taiwan, and provides ODM/OEM manufacturing services for scar gels for Malaysian clients. In addition to continuously supplying bone graft products to clients in Brazil, the company is also actively pursuing certification for locally developed dressing products. By diversifying its product portfolio, ORDL continues to strengthen its presence in international markets.
With the strong support of the Far Eastern Group, ORDL continues to focus on the innovative research and development of medical device products and the expansion of its global markets. Recognized for its exceptional product quality and remarkable export performance, the company has been honored with the 28th Rising Star Award. This recognition highlights its competitiveness and growth potential on the international stage.
Looking ahead, ORDL will continue to enforce the presence in the Southeast Asian and US markets. The company will actively strengthen its key role in the global supply chain, and remain committed to enhancing global healthcare quality through innovations. ORDL aims to provide patients worldwide with safer, higher-quality healthcare experiences, fulfilling its vision of expanding from Taiwan to the world and driving innovation in medical devices for global health.
2025/11/24
in e-News